ShanXi C&Y Pharmaceutical Group Co.,LTD. (SHE:300254)

SHE:300254 Revenue

ShanXi C&Y Pharmaceutical Group Co.,LTD. had revenue of 186.37M CNY in the quarter ending September 30, 2026, a decrease of -21.85%. This brings the company's total for the last twelve months to 797.57M, down -6.09% year-over-year. In the year 2025, ShanXi C&Y Pharmaceutical Group Co.,LTD. had annual revenue of 870.79M with 2.86% growth. That makes ShanXi C&Y Pharmaceutical Group Co.,LTD. the 21,351st largest company in the world by revenue and 3,922nd in China.

• Revenue (ttm): 797.57M
• Revenue Growth: -6.09%
• P/S Ratio: 2.39
• Revenue / Employee: 686.38K
• Employees: 1,162
• Market Cap: 1.91B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Medicine 812.91M 93.4%
• Business 37.53M 4.3%
• Services 11.25M 1.3%
• Health Food 6.48M 0.7%
• Unallocated Other Business 2.62M 0.3%

By Geography

Chart

• East China 381.38M 43.8%
• Central China 132.73M 15.2%
• South-West China 112.09M 12.9%
• North China 106.10M 12.2%
• South China 69.77M 8.0%
• North-West China 40.64M 4.7%
• Northeast China 27.86M 3.2%
• Overseas 205.54K 0.0%

Fiscal year ended Dec 31, 2025 See the full SHE:300254 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	870.79M	24.18M	2.86%
Dec 31, 2024	846.61M	47.30M	5.92%
Dec 31, 2023	799.31M	-29.69M	-3.58%
Jan 1, 2023	829.00M	-101.38M	-10.90%
Jan 1, 2022	930.37M	82.30M	9.70%

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 8, 2026

Data Sources Report a data error